Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

  • CEO: Gordon Sanghera
  • Website: www.nanoporetech.com
  • Ticker symbol: Privately held
  • Headquarters: Oxford, UK
  • Number of employees: 250+
Aug 14, 2020

In Brief This Week: BGI, Illumina, Pacific Biosciences, Oxford Nanopore, Co-Diagnostics, More

News items for the week of August 10, 2020.

Aug 11, 2020

Numbers Needed

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

Aug 03, 2020

Fast COVID-19 Testing for UK

The UK is implementing COVID-19 testing with a 90-minute turnaround time.

Aug 03, 2020

NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

Both tests can detect SARS-CoV-2 in 90 minutes and will detect viruses like influenza and respiratory syncytial virus that tend to occur in the winter.

Jul 09, 2020

Dual-Reader Nanopore Promises Improved Homopolymer Sequencing Accuracy

Premium

The new pore, a complex between E. coli CsgG and part of CsgF, called certain homopolymers more accurately than an engineered version of CsgG.

Jun 26, 2020

New Products Posted to GenomeWeb: Oxford Nanopore, Guardant Health, IDT, More

May 28, 2020

Oxford Nanopore Technologies Raises £48.4M in Private Financing

The company is also working on a diagnostic COVID-19 test, called LamPore, that will run on its MinIon and GridIon nanopore sequencing platforms

Apr 22, 2020

New Zealand Funds Research Pairing Ubiquitome, Oxford Nanopore Devices for SARS-CoV-2 Detection

Combining Ubiquitome's handheld PCR device and Oxford Nanopore's sequencer may enable a single person to screen 500 samples and obtain 24 whole genome sequences per day.

Apr 10, 2020

Korean Researchers Map SARS-CoV-2 Transcriptomic Architecture

The researchers said a functional investigation of the virus' unknown transcripts and RNA modifications will elucidate its life cycle and pathogenicity.

Mar 31, 2020

The Decade in Genomics: CRISPR, Single Cells, Long Reads, Clinical and Consumer Applications

Premium

GenomeWeb asked a number of prominent researchers in the field via email about their top picks for notable developments or achievements in genomics during the 2010s.

Pages

The Scan

National Academy of Sciences May Expel Members

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

More to Mix and Match

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

Nucleic Acids Research Papers on DNA-Bound Proteins, Transcriptional Activation, More

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.